Sara Pressel

6.9k total citations · 1 hit paper
58 papers, 2.4k citations indexed

About

Sara Pressel is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Economics and Econometrics. According to data from OpenAlex, Sara Pressel has authored 58 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cardiology and Cardiovascular Medicine, 18 papers in Endocrinology, Diabetes and Metabolism and 14 papers in Economics and Econometrics. Recurrent topics in Sara Pressel's work include Blood Pressure and Hypertension Studies (30 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers) and Hormonal Regulation and Hypertension (12 papers). Sara Pressel is often cited by papers focused on Blood Pressure and Hypertension Studies (30 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers) and Hormonal Regulation and Hypertension (12 papers). Sara Pressel collaborates with scholars based in United States, Netherlands and Canada. Sara Pressel's co-authors include Barry R. Davis, B. Frank Polk, Bernard Rosner, Kenneth A. Schneider, J. Steven Morris, William C. Cushman, Nora M. Cosgrove, John B. Kostis, Joshua I. Barzilay and Paul K. Whelton and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Sara Pressel

58 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PREDIAGNOSTIC SERUM SELENIUM AND RISK OF CANCER

1983 437 citations J. Steven Morris, Sara Pressel et al. The Lancet profile →

Peers

Countries citing papers authored by Sara Pressel

Since Specialization

Citations

This map shows the geographic impact of Sara Pressel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Pressel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Pressel more than expected).

Fields of papers citing papers by Sara Pressel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Pressel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Pressel. The network helps show where Sara Pressel may publish in the future.

Co-authorship network of co-authors of Sara Pressel

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Pressel. A scholar is included among the top collaborators of Sara Pressel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Pressel. Sara Pressel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Impact of Antihypertensive Medications on Bone Mineral Density and Fracture Risk 2017 ·Current Cardiology Reports ·Joshua I. Barzilay, Barry R. Davis, Sara Pressel, Alokananda Ghosh, (unknown), Karen L. Margolis, Paul K. Whelton	28
2	Effect of Statin Treatment vs Usual Care on Primary Cardiovascular Prevention Among Older Adults 2017 ·JAMA Internal Medicine ·Benjamin H. Han, (unknown), Jeff D. Williamson, Barry R. Davis, Linda B. Piller, (unknown), Sara Pressel, Caroline Blaum	120
3	Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus 2016 ·Circulation Cardiovascular Quality and Outcomes ·Lotte Kaasenbrood, Neil R Poulter, Peter S. Sever, Helen M. Colhoun, Shona Livingstone, S. Matthijs Boekholdt, Sara Pressel, Barry R. Davis, Yolanda van der Graaf, Frank L.J. Visseren	9
4	ASSOCIATION OF ORTHOSTATIC HYPERTENSION WITH MORTALITY IN THE SYSTOLIC HYPERTENSION IN THE ELDERLY PROGRAM 2016 ·Journal of the American College of Cardiology ·William J. Kostis, Abel E. Moreyra, Davit Sargsyan, Javier Cabrera, Nora M. Cosgrove, John B. Kostis, William C. Cushman, John Pantazopoulos, Sara Pressel, Barry R. Davis	2
5	Treatment-Resistant Hypertension and Outcomes Based on Randomized Treatment Group in ALLHAT 2016 ·The American Journal of Medicine ·Sripal Bangalore, Barry R. Davis, William C. Cushman, Sara Pressel, Paul Muntner, David A. Calhoun, John B. Kostis, Paul K. Whelton, Jeffrey L. Probstfield, Mahboob Rahman, Henry R. Black	11
6	Association of 3 Different Antihypertensive Medications With Hip and Pelvic Fracture Risk in Older Adults 2016 ·JAMA Internal Medicine ·(unknown), Barry R. Davis, Sara Pressel, Paul K. Whelton, William C. Cushman, Gail T. Louis, Karen L. Margolis, Suzanne Oparil, Jonathan S. Williams, Alokananda Ghosh, Paula T. Einhorn, Joshua I. Barzilay	45
7	Should Antihypertensive Treatment Recommendations Differ in Patients With and Without Coronary Heart Disease? (from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT]) 2015 ·The American Journal of Cardiology ·Michael H. Alderman, Barry R. Davis, Linda B. Piller, Charles E. Ford, (unknown), Sara Pressel, (unknown), Paula T. Einhorn, L. Julian Haywood, (unknown), Suzanne Oparil, Tamrat M. Retta	6
8	Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT 2014 ·Journal of the American Society of Hypertension ·José-Miguel Yamal, Suzanne Oparil, Barry R. Davis, Michael H. Alderman, David A. Calhoun, William C. Cushman, (unknown), Stanley S. Franklin, Gabriel B. Habib, Sara Pressel, Jeffrey L. Probstfield, Sithiporn Sastrasinh	14
9	Long-Term Effects of Incident Diabetes Mellitus on Cardiovascular Outcomes in People Treated for Hypertension 2012 ·Circulation Cardiovascular Quality and Outcomes ·Joshua I. Barzilay, Barry R. Davis, Sara Pressel, Jeffrey A. Cutler, Paula T. Einhorn, Henry R. Black, William C. Cushman, Charles E. Ford, Karen L. Margolis, Jamaluddin Moloo, Suzanne Oparil, Linda B. Piller, Debra L. Simmons, Mary Ellen Sweeney, Paul K. Whelton, Nathan D. Wong, Jackson T. Wright	48
10	ALLHAT: still providing correct answers after 7 years 2010 ·Current Opinion in Cardiology ·Paula T. Einhorn, Barry R. Davis, Jackson T. Wright, Mahboob Rahman, Paul K. Whelton, Sara Pressel	9
11	Getting clinical trial results into practice: design, implementation, and process evaluation of the ALLHAT Dissemination Project 2009 ·Clinical Trials ·L. Kay Bartholomew, William C. Cushman, Jeffrey A. Cutler, Barry R. Davis, (unknown), Paula T. Einhorn, James F. Graumlich, Linda B. Piller, Sara Pressel, Edward J. Roccella, Lara M. Simpson, Paul K. Whelton, (unknown)	15
12	Management of High Blood Pressure in Clinical Practice: Perceptible Qualitative Differences in Approaches Utilized by Clinicians 2008 ·Journal of Clinical Hypertension ·Chuke Nwachuku, Arnaud Bastien, Jeffrey A. Cutler, (unknown), Karen L. Margolis, Edward J. Roccella, Sara Pressel, Barry R. Davis, (unknown), Sheldon G. Sheps, Michael A. Weber	7
13	Progression of Kidney Disease in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin Versus Usual Care: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) 2008 ·American Journal of Kidney Diseases ·Mahboob Rahman, (unknown), Barry R. Davis, Joshua I. Barzilay, Jan Basile, Mario Henriquez, Anne M. Huml, Nelson Kopyt, Gail T. Louis, Sara Pressel, Clive Rosendorff, Sithiporn Sastrasinh, (unknown)	72
14	Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes 2004 ·The American Journal of Cardiology ·John B. Kostis, Alan C. Wilson, Ronald S. Freudenberger, Nora M. Cosgrove, Sara Pressel, Barry R. Davis	188
15	The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) 2001 ·Controlled Clinical Trials ·Jackson T. Wright, William C. Cushman, Barry R. Davis, Joshua I. Barzilay, Pedro Colon, Debra Egan, (unknown), Chuke Nwachuku, Sara Pressel, Frans H. H. Leenen, Joseph P. Frolkis, Rebecca Letterer, Sandra Walsh, Jonathan N. Tobin, (unknown)	237
16	Operational Aspects of Terminating the Doxazosin Arm of the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) 2001 ·Controlled Clinical Trials ·Sara Pressel, Barry R. Davis, (unknown), (unknown), (unknown), Charles E. Ford, Linda B. Piller, Judy Bettencourt, Barbara Kimmel, Christine M. Lusk, (unknown), Lara M. Simpson, Chuke Nwachuku, Curt D. Furberg	14
17	Clinical Trial Participant Satisfaction: Survey of SHEP Enrollees 1997 ·Journal of the American Geriatrics Society ·Eleanor Schron, Sylvia Wassertheil‐Smoller, Sara Pressel	38
18	Correlates of ventricular ectopic activity in isolated systolic hypertension 1994 ·American Heart Journal ·John B. Kostis, (unknown), David M. Berkson, J. David Curb, Janice A. Davey, Richard H. Grimm, Wayne Hall, Clifton R. Lacy, Marshall Lee, Stephen T. Miller, Sara Pressel, Ronald J. Prineas	11
19	Statistical considerations in monitoring the Systolic Hypertension in the Elderly Program (SHEP) 1993 ·Controlled Clinical Trials ·Barry R. Davis, Janet Wittes, Sara Pressel, Kenneth G. Berge, C. Hawkins, Edward Lakatos, Lemuel A. Moyé, Jeffrey L. Probstfield	11
20	PREDIAGNOSTIC SERUM SELENIUM AND RISK OF CANCER breakdown → 1983 ·The Lancet ·(unknown), J. Steven Morris, Sara Pressel, (unknown), B. Frank Polk, (unknown), Bernard Rosner, Kenneth A. Schneider, (unknown)	437

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact